Astepro (Meda Pharmaceuticals Inc.)
Welcome to the PulseAid listing for the Astepro drug offered from Meda Pharmaceuticals Inc.. This Histamine H1 Receptor Antagonists [MoA],Histamine-1 Receptor Antagonist [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Meda Pharmaceuticals Inc. |
| NON-PROPRIETARY NAME: | Azelastine Hydrochloride |
| SUBSTANCE NAME: | AZELASTINE HYDROCHLORIDE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Histamine H1 Receptor Antagonists [MoA],Histamine-1 Receptor Antagonist [EPC] |
| ROUTE: | NASAL |
| DOSAGE FORM: | SPRAY, METERED |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2009-10-12 |
| END MARKETING DATE: | 0000-00-00 |
Astepro HUMAN PRESCRIPTION DRUG Details:
| Item Description | Astepro from Meda Pharmaceuticals Inc. |
| LABELER NAME: | Meda Pharmaceuticals Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 205.5(ug/1) |
| START MARKETING DATE: | 2009-10-12 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0037-0243_98263b8c-1476-4df0-b663-f5cb946b2fd8 |
| PRODUCT NDC: | 0037-0243 |
| APPLICATION NUMBER: | NDA022203 |
Other AZELASTINE HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers:
